Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 1

1(14.3%)

Phase 4

1(14.3%)

7Total

N/A(5)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01167907Not ApplicableCompleted

Evaluation of Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block After Ankle Surgery

Role: collaborator

NCT00638508Phase 4Completed

ON-Q Pump Infusion of Ketorolac and Ropivacaine at the Wound Site for Postoperative Pain Management

Role: collaborator

NCT00373633Phase 1Terminated

Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain

Role: collaborator

NCT01401712Not ApplicableUnknown

Optimal Method of Pain Management in Patients With Multiple Rib Fractures

Role: collaborator

NCT00500565Not ApplicableCompleted

Pain Management Following TRAM Flap for Breast Reconstruction

Role: collaborator

NCT01593280Not ApplicableUnknown

TAP Catheters Versus Intrathecal Morphine for Cesarean Section

Role: collaborator

NCT01589796Not ApplicableUnknown

Medial Versus Traditional Approach to US-guided TAP Blocks for Open Inguinal Hernia Repair

Role: collaborator

All 7 trials loaded